[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-514836-105":59,"doc-detail-514836-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","flexsbdd-structure-based-drug-design-with-flexible-protein-modeling-paper","FlexSBDD - Structure-Based Drug Design with Flexible Protein Modeling - Paper","","Structure-based drug design (SBDD) aims to generate 3D ligand molecules that bind target proteins, yet most existing approaches assume rigid proteins and ignore binding-induced conformational change, producing unrealistic complexes with issues such as steric clashes. FlexSBDD is introduced as a deep generative framework for accurately modeling flexible protein-ligand complexes while generating ligands. It uses a flow-matching strategy with an E(3)-equivariant scalar-vector dual network and employs relaxation and sidechain repacking augmentations. Extensive experiments show state-of-the-art molecule generation with higher affinity, improved hydrogen-bonding interactions, and reduced steric clashes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/flexsbdd-structure-based-drug-design-with-flexible-protein-modeling-paper/514836/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/flexsbdd-structure-based-drug-design-with-flexible-protein-modeling-paper/514836.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-10-06",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does FlexSBDD address in structure-based drug design?","Question",{"text":112,"@type":113},"FlexSBDD addresses the gap caused by rigid-protein assumptions in existing SBDD methods, which neglect protein conformational changes upon ligand binding and lead to sub-optimal complexes such as steric clashes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does FlexSBDD model flexible protein-ligand complexes?",{"text":117,"@type":113},"FlexSBDD uses an efficient flow-matching framework together with an E(3)-equivariant network using scalar-vector dual representation to model dynamic structural changes during generation.",{"name":119,"@type":110,"acceptedAnswer":120},"What data and augmentation strategy does FlexSBDD use?",{"text":121,"@type":113},"FlexSBDD employs the Apobind dataset and augments it with additional apo data generated by OpenMM relaxation and Rosetta sidechain repacking to better learn apo-holo changes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},514836,1791397366,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","FlexSBDD: Structure-Based Drug Design with Flexible  \nProtein Modeling  \nZaixi Zhang 1 ,2 ,3 , Mengdi Wang3 , Qi Liu 1 ,2   \n1: School of Computer Science and Technology, University of Science and Technology of China 2:State Key Laboratory of Cognitive Intelligence, Hefei, Anhui, China 3:Princeton University  \n[zaixi@mail.ustc.edu.cn](zaixi@mail.ustc.edu.cn), [mengdiw@princeton.edu](mengdiw@princeton.edu), [qiliuql@ustc.edu.cn](qiliuql@ustc.edu.cn)  \nAbstract  \nStructure-based drug design (SBDD), which aims to generate 3D ligand molecules binding to target proteins, is a fundamental task in drug discovery. Existing SBDD methods typically treat protein as rigid and neglect protein structural change when binding with ligand molecules, leading to a big gap with real-world scenarios and inferior generation qualities (e.g., many steric clashes) . To bridge the gap, we propose FlexSBDD, a deep generative model capable of accurately modeling the flexible protein-ligand complex structure for ligand molecule generation. FlexSBDD adoptsan efficient flow matching framework and leverages E(3)-equivariant network with scalar-vector dual representation to model dynamic structural changes. Moreover, novel data augmentation schemes based on structure relaxation/sidechain repacking are adopted to boost performance. Extensive experiments demonstrate that FlexSBDD achieves state-of-the-art performance in generating high-affinity molecules and effectively modeling the protein’s conformation change to increase favorable protein-ligand interactions (e.g., Hydrogen bonds) and decrease steric clashes.  \n1 Introduction  \nDeep generative models are profoundly impacting drug discovery, particularly within the challenging subfield of structure-based drug design (SBDD) [1, 54, 36] . SBDD focuses on generating drug-like ligand molecules conditioned on target-binding proteins, necessitating precise modeling of complex geometric structures and detailed protein-ligand interactions. Some early attempts adopt autoregressive models to generate 3D ligand molecules atom-by-atom [53, 57] or fragment-by-fragment [85] . To overcome the limitations of autoregressive methods (e.g., error accumulation), recent works [28, 29] leverage non-autoregressive diffusion-based models [31] to predict the distribution of ligand atom types and positions via denoising and have achieved the state-of-the-art performance.  \nDespite the remarkable success, most existing SBDD models treat target proteins as rigid and neglect the conformation change. However, according to the “induced fit” theory in biochemistry [43], proteins are flexible structures that undergo structural changes upon ligand binding, leading to enhanced interactions and binding affinity. In structural biology, the protein structure that has a bound small molecule is referred to as ligand-bound or holo conformation, and the protein structure without a bound small molecule is called ligand-free or apo conformation [16] . For example, Figure. 1 (a)&(b) shows the aligned apo and holo-structures of two proteins, and the extent of structural change is influenced by the specific properties and structures of the proteins and ligands. The neglect of protein flexibility in SBDD leads to several significant drawbacks: (1) The generated protein-ligand complexes are prone to have sub-optimal protein structures and steric clashes as the protein cannot adaptively adjust structures according to different generated molecules [30] . (2) The chemical search  \n∗ Qi Liu is the corresponding authors.  \n38th Conference on Neural Information Processing Systems (NeurIPS 2024) .  \nspace is overly restricted by existing holo data, limiting the exploration of diverse high-quality drugs. As a result, SBDD models tend to produce molecules that are similar to those fitting the predefined pocket space [53, 62] . (3) A large gap between real-world physical binding process and computational simulations, which may lead to high false positive rates in rea","cbCaiqckjkZKgqeA","https://ap.wps.com/l/cbCaiqckjkZKgqeA","pdf",4052692,27,"English","# Introduction\n## Challenges in rigid-protein SBDD\n## Key challenges for flexible protein modeling\n## Proposed method: FlexSBDD","[{\"question\":\"What problem does FlexSBDD address in structure-based drug design?\",\"answer\":\"FlexSBDD addresses the gap caused by rigid-protein assumptions in existing SBDD methods, which neglect protein conformational changes upon ligand binding and lead to sub-optimal complexes such as steric clashes.\"},{\"question\":\"How does FlexSBDD model flexible protein-ligand complexes?\",\"answer\":\"FlexSBDD uses an efficient flow-matching framework together with an E(3)-equivariant network using scalar-vector dual representation to model dynamic structural changes during generation.\"},{\"question\":\"What data and augmentation strategy does FlexSBDD use?\",\"answer\":\"FlexSBDD employs the Apobind dataset and augments it with additional apo data generated by OpenMM relaxation and Rosetta sidechain repacking to better learn apo-holo changes.\"}]","FlexSBDD - Structure-Based Drug Design with Flexible Protein Modeling - Paper | PDF",1791302447,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1365eda686ee93a73232ae1f2797aa6e.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/3c8a687eb90450dd84401f735610f7e3.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/d9576c4fceba30c75782d5e66ede33ea.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/8450a56fcac9717e6acfcdba1a15f30c.webp",980,1268]